Monday, August 15, 2022 | Back issues
Courthouse News Service Courthouse News Service

Patent & Trademark

Sanofi-Aventis claims Genentech and Biogen IDEC violate its patents on "nucleic acid enhancers" to make biotherapeutic cancer drugs, including Avastin, Herceptin, and Rituxan, in Lufkin, Texas, Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.